Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
Phase 3
Completed
- Conditions
- Dry Eye Syndromes
- Registration Number
- NCT00549289
- Lead Sponsor
- Sirion Therapeutics, Inc.
- Brief Summary
The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosis of dry eye syndrome
Exclusion Criteria
- Intraocular or refractive surgery in the study eye within 3 months prior to study start
- Unwilling to discontinue use of contact lenses during the study
- Pregnancy or lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Clayton Eye Center
🇺🇸Morrow, Georgia, United States